Gossamer Bio, Inc. (GOSS)

0.1753 0.00 (0.00%) USD  |  NASDAQ  |  Sep 04, 16:00
0.1752 0.00 (0.00%) After-Hours: 20:00
More

Gossamer Bio Cash and Short Term Investments (Annual) : 136.93M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for GOSS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2016. Start Trial.
Date Value
December 31, 2025 136.93M
December 31, 2024 294.52M
December 31, 2023 296.42M
December 31, 2022 255.68M
December 31, 2021 325.28M
Date Value
December 31, 2020 513.19M
December 31, 2019 401.83M
December 31, 2018 228.86M
December 31, 2017 0.315M
December 31, 2016 0.06M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Arbutus Biopharma Corp. 91.47M
Kura Oncology, Inc. 667.24M
ACADIA Pharmaceuticals, Inc. 819.69M
Alnylam Pharmaceuticals, Inc. 2.908B
Anika Therapeutics, Inc. 57.48M